4/A: Helios Technologies CFO Sean Bagan Corrects Stock Option Grant in Amended SEC Filing

Sentiment:

SEC Filing


Sean Bagan, CFO of Helios Technologies, files an amended SEC Form 4 to correct the number of stock options granted to him, changing the originally reported 2,243 to 5,342.

Summary

  • Sean Bagan, the Chief Financial Officer of Helios Technologies, filed an amended Form 4 with the SEC.
  • The amendment corrects an error in the original filing regarding the number of stock options granted to him.
  • The original Form 4, filed on September 13, 2024, incorrectly stated the number of stock options as 2,243.
  • The corrected filing shows that Mr. Bagan was granted 5,342 stock options on September 11, 2024.
  • These options vest and become exercisable on the third anniversary of the grant date, September 11, 2027, unless forfeited earlier.

Sentiment

Score: 7

Explanation: The document is a routine correction of an administrative error in an SEC filing. It doesn't indicate any fundamental issues with the company, but it does highlight a need for improved accuracy in reporting. The sentiment is neutral to slightly positive due to the transparency of correcting the error.

Industry Context

This is a routine SEC filing related to executive compensation. Such filings are common for publicly traded companies and provide transparency regarding stock options and other equity-based compensation granted to executives.

Comparison to Industry Standards

  • Stock option grants are a common form of executive compensation in publicly traded companies.
  • The vesting schedule of three years is fairly standard.
  • Companies like Parker Hannifin (PH) and Eaton Corporation (ETN), which operate in similar industrial sectors, also utilize stock options as part of their executive compensation packages.
  • The specific number of options granted and the exercise price are company-specific and depend on factors such as company performance, executive responsibilities, and overall compensation strategy.

Stakeholder Impact

  • The correction of the stock option grant ensures accurate reporting to shareholders.
  • It has a minor positive impact on stakeholders by demonstrating transparency and adherence to regulatory requirements.

Key Dates

DateDescription
09/11/2024Date of stock options grant to Sean Bagan
09/11/2027Date when stock options vest and become exercisable
09/11/2034Expiration date of the stock options
09/13/2024Date of original Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.